Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Human Genome Sciences claims new growth factor

Oct. 11, 1996

Ciba-Geigy reports on further NK1 antagonists

Oct. 11, 1996

Glaxo Wellcome reports new diuretics

Oct. 4, 1996

Fibrinogen antagonists reported by Searle

Oct. 4, 1996

Boehringer Mannheim reports fibrinogen antagonists for thromboembolic conditions

Oct. 4, 1996

HLE inhibitors described by Zeneca

Oct. 4, 1996

Natural cAMP phosphodiesterase inhibitor reported by Nippon Kayaku

Oct. 4, 1996

Zeneca claims new antiasthma agents

Oct. 4, 1996

Calpain inhibitors from Fujirebio

Oct. 4, 1996

Astra NOS inhibitors as neuroprotectants

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...